News & Blog

Common gastric acid medicine may target tuberculosis

A drug that is commonly used to treat conditions such as heartburn, gastritis and ulcers could work against the bacteria that cause tuberculosis (TB). Photo | Generic pills Pixabay CCO The study, led by the London School of Hygiene & Tropical Medicine and UCL and published in PLOS Medicine, found that people who used lansoprazole, […]

MOOC Tuberculosis | New Free Online Course Launched by Institut Pasteur

This course covers a broad range of topics on TB, from the basics of the disease to the latest discoveries, including the clinical picture, epidemiology, pediatric TB, increased susceptibility caused by HIV, diabetes and genetic factors, the host immune response, vaccines, diagnosis, the rapid detection of drug resistance, Whole Genome Sequencing and the treatment of both […]

WHO News | WHO Compendium of TB Guidelines and Associated Standards

Content from WHO Newsflash 03/11/2017 ‘3 November 2017 | Geneva: The Global Tuberculosis Programme of the World Health Organization (WHO) has released the “Compendium of WHO guidelines and associated standards” to support the delivery of care for all persons affected by tuberculosis (TB). ‘The Compendium has been developed as a clear and concise instrument to […]

Presentations, press briefing and Health Policy and Planning supplement

2017 World Lung Health Conference Accelerating Towards Elimination was the theme of the 2017 World Lung Health Conference held in the quaint city of Guadalajara, Mexico from 11 – 14 October.  Delegates from more than 100 countries attended the packed schedule of plenaries, symposia and abstracts and researchers from the TB Centre had a very […]

Video | Tackling TB: TB Centre Retreat 2017

In September 2017 the TB Centre held our retreat where we discussed some of the biggest problems facing TB research and how the Centre is working to tackle these problems. This video gives a flavour of some of the research covered and the importance this has to individuals with TB. Watch the video here.  TB […]

Global TB Programme consultancy

The purpose of this assignment is to support the Global TB Programme (GTB) and, more specifically, the Technical Support Coordination (TSC) team, in (technical assistance (TA)) related work streams relevant to Global Fund applications, The Global Fund grant negotiation process, as well as implementation of Global Fund financed TB and TB/HIV grants. More specifically, with […]

Research to fight tuberculosis

LSHTM researchers have been awarded separately funded projects within TBVAC2020 to help support the discovery and development of novel TB vaccines: Greg Bancroft, Helen Fletcher/Andrea Zelmer, and Hazel Dockrell /Steven Smith. TBVAC2020 is a research project supported by the Horizon 2020 program of the European Commission (EC). It aims at the discovery and development of novel […]

London School of Hygiene & Tropical Medicine’s Professor Clark shortlisted for prestigious Newton Prize

Professor Taane Clark has been shortlisted for the 2017 Newton Prize for his project tackling infectious diseases with genome technology in Thailand. The Newton Prize The Prize is an annual £1 million fund awarded for the best research or innovation that supports the economic development and social welfare of developing countries. Professor Clark is in […]

We need to talk about TB | Led by RESULTS-UK: Voices Changing the World

LSHTM Week 2017 RESULTS is a movement of committed, everyday people who together use their voices to influence political decisions that will bring an end to poverty. In 2017/2018 there are a series of high-level political meetings which aim to change the way we are tackling tuberculosis.  RESULTS are working to educate and advise policy […]

BCG vaccination may protect against TB for nearly twice as long as previously thought

Study shows vaccine guards against infection in adulthood when most transmission occurs Image: Digitally-colorized scanning electron microscopic image of orange-colored, rod-shaped Mycobacterium tuberculosis bacteria. Credit: NIAID/CDC The world’s only licensed tuberculosis (TB) vaccine could offer protection against the disease for nearly twice as long as previously thought, according to new research published in the International Journal […]